JFS Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

JFS Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85K	Hold	10	–	–	﹤0.01%	1487
2026 Q1	$2.97K	Hold	10	–	–	﹤0.01%	1391
2025 Q4	$3.04K	Hold	10	–	–	﹤0.01%	1421
2025 Q3	$3.41K	Hold	10	–	–	﹤0.01%	1271
2025 Q2	$2.42K	Hold	10	–	–	﹤0.01%	1346
2025 Q1	$2.72K	Buy	10 +2	+25%	+$468	﹤0.01%	1350
2024 Q4	$1.48K	Sell	8 -2	-20%	-$409	﹤0.01%	1582
2024 Q3	$2.25K	Buy	10 +4	+67%	+$720	﹤0.01%	1433
2024 Q2	$857	Hold	6	–	–	﹤0.01%	1699
2024 Q1	$939	Sell	6 -1	-14%	-$161	﹤0.01%	1679
2023 Q4	$1.26K	Buy	7 +1	+17%	+$181	﹤0.01%	1578
2023 Q3	$1.08K	Hold	6	–	–	﹤0.01%	1576
2023 Q2	$1.07K	Hold	6	–	–	﹤0.01%	1581
2023 Q1	$1.29K	Hold	6	–	–	﹤0.01%	1511
2022 Q4	$1.32K	Buy	6 +1	+20%	+$183	﹤0.01%	1520
2022 Q3	$1K	Buy	+5	New	+$859	﹤0.01%	1688
2022 Q2	–	Sell	-46	Closed	-$9K	–	1969
2022 Q1	$9K	Buy	46 +41	+820%	+$8.72K	﹤0.01%	845
2021 Q4	$1K	Buy	+5	New	+$1.69K	﹤0.01%	1631

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JFS Wealth Advisors's ONC Position: Q2 2026 in Review

JFS Wealth Advisors held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 10 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

JFS Wealth Advisors first reported a position in ONC in Q4 2021 and has held it in 18 quarters since. The position peaked at $9K in Q1 2022. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

JFS Wealth Advisors held 10 shares of BeOne Medicines Ltd worth $2.85K as of Q2 2026.
JFS Wealth Advisors left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1487 holding.
JFS Wealth Advisors first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 18 quarters since.
JFS Wealth Advisors's BeOne Medicines Ltd position peaked at $9K in Q1 2022.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.